SMITHS FALLS, ONT. — Canopy Growth Corp. says it has signed a deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary to German company Dermapharm Holding SE. Under the agreement, Canopy will receive an upfront payment of $115.5 million.
Read more >